Free Trial

Hellenic Dynamics (HELD) Competitors

GBX 1.15
-0.03 (-2.54%)
(As of 07/15/2024 ET)

HELD vs. N4P, HLN, HIK, HCM, INDV, AMYT, BMK, AGY, APH, and BXP

Should you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include N4 Pharma (N4P), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Benchmark (BMK), Allergy Therapeutics (AGY), Alliance Pharma (APH), and Beximco Pharmaceuticals (BXP). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Hellenic Dynamics vs.

Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hellenic DynamicsN/AN/AN/AN/AN/A
N4 Pharma£23.52K57.13-£1.27M-£0.01-50.00

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hellenic Dynamics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
N4 Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.

CompanyUnderperformOutperform
Hellenic DynamicsN/AN/A
N4 PharmaOutperform Votes
103
65.61%
Underperform Votes
54
34.39%

0.1% of Hellenic Dynamics shares are owned by institutional investors. 72.9% of Hellenic Dynamics shares are owned by insiders. Comparatively, 23.1% of N4 Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Hellenic Dynamics' average media sentiment score of 0.00 equaled N4 Pharma'saverage media sentiment score.

Company Overall Sentiment
Hellenic Dynamics Neutral
N4 Pharma Neutral

Hellenic Dynamics' return on equity of 0.00% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Hellenic DynamicsN/A N/A N/A
N4 Pharma N/A -77.81%-51.74%

Summary

Hellenic Dynamics beats N4 Pharma on 4 of the 6 factors compared between the two stocks.

Get Hellenic Dynamics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HELD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HELD vs. The Competition

MetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.57M£1.24B£5.25B£1.44B
Dividend YieldN/A3.07%5.24%11.92%
P/E RatioN/A340.62127.221,660.90
Price / SalesN/A5,981.152,247.74320,238.72
Price / CashN/A10.1832.3633.53
Price / BookN/A5.644.942.74
Net IncomeN/A£148.96M£108.08M£171.47M
7 Day Performance-9.02%0.73%5.58%5.07%
1 Month Performance-19.71%63.26%6.13%2.93%
1 Year PerformanceN/A100.59%6.64%20.11%

Hellenic Dynamics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
N4P
N4 Pharma
0 of 5 stars
0.00 / 5 stars
GBX 0.43
flat
N/A-72.1%£1.14M£23,524.00-42.505Gap Up
HLN
Haleon
0.0825 of 5 stars
0.08 / 5 stars
GBX 326.70
+0.4%
GBX 356
+9.0%
+7.2%£29.83B£11.24B2,722.5025,408
HIK
Hikma Pharmaceuticals
2.0879 of 5 stars
2.09 / 5 stars
GBX 1,809
-0.5%
GBX 2,225
+23.0%
+1.5%£4.01B£2.88B2,700.009,100
HCM
HUTCHMED
0 of 5 stars
0.00 / 5 stars
GBX 265
-8.9%
N/A+49.8%£2.26B£838M2,650.001,988Gap Down
High Trading Volume
INDV
Indivior
1.4513 of 5 stars
1.45 / 5 stars
GBX 1,181
+1.8%
GBX 2,700
+128.6%
-53.2%£1.60B£1.12B39,366.671,000
AMYT
Amryt Pharma
0 of 5 stars
0.00 / 5 stars
N/AN/A+0.0%£457.11M£210.24M-4.332,020Gap Down
BMK
Benchmark
0 of 5 stars
0.00 / 5 stars
GBX 38
-6.1%
N/A-3.6%£281.11M£155.53M-1,266.67823Gap Down
AGY
Allergy Therapeutics
0 of 5 stars
0.00 / 5 stars
GBX 5
+5.3%
N/A+165.7%£238.50M£53.26M-83.33612
APH
Alliance Pharma
2.1015 of 5 stars
2.10 / 5 stars
GBX 36.75
-2.3%
GBX 56.50
+53.7%
-18.2%£198.60M£170.05M-3,675.00285
BXP
Beximco Pharmaceuticals
0 of 5 stars
0.00 / 5 stars
GBX 38.50
flat
N/A+5.5%£171.75M£43.08B481.255,700

Related Companies and Tools

This page (LON:HELD) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners